UBS Group »

Janux Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $836k 22k 37.65
2023-03-31 $10k 841 12.10
2022-12-31 $2.8k 213 13.17
2022-03-31 $50k 3.5k 14.29
2021-12-31 $73k 3.7k 19.71
2021-09-30 $76k 3.5k 21.71
2021-06-30 $9.0k 353 25.50